Lars Holten-Andersen

Director
Preclinical Development
Ascendis Pharma
Denmark

Business Expert Toxicology
Biography

"Københavns Universitet Degree Name PhD Field Of Study Clinical diagnostics Dates attended or expected graduation 2004 – 2008 PhD thesis: Investigating salivary TIMP-1 as a potential molecular marker in colorectal cancer Investigating saliva as a diagnostic tool - focus on cancer markers (TIMP-1 and MMPs). Development of a highly sensitive and specific ELISA for early detection of CRC patients. Performed at the Faculty of Health Sciences, University of Copenhagen. Supervised by: Prof. Birgitte Nauntofte, CEO, the Novo Nordisk Foundation Prof. Nils Brünner, Director, the Sino-Danish Breast Cancer Research Centre at LIFE and CEO of WntResearch AB Prof. Hans Jørgen Nielsen, Department of Surgical Gastroenterology, Hvidovre Hospital"  

Research Intrest

Toxicology